Embecta Corp. (EMBC): Gross Profit

Annual figures by period end, from SEC filings.

$676.80M
Year ended 2025-09-30
$601.30M
Trailing 12 months to 2026-06-30
-4.4%
3-year compound annual growth
-2.4%
5-year compound annual growth
$800.40M2020-09-30: $762.60M2021-09-30: $800.40M2022-09-30: $774.90M2023-09-30: $749.90M2024-09-30: $735.20M2025-09-30: $676.80M$676.80M
2020-09-30 Gross Profit (USD) 2025-09-30
Period endedGross ProfitChange YoYSource filing
2025-09-30$676.80M-7.9%2025-11-25, From 2024-10-01
2024-09-30$735.20M-2.0%2025-11-25, From 2023-10-01
2023-09-30$749.90M-3.2%2025-11-25, From 2022-10-01
2022-09-30$774.90M-3.2%2024-12-11, From 2021-10-01
2021-09-30$800.40M+5.0%2023-11-29, From 2020-10-01
2020-09-30$762.60Mn/a2022-12-22, From 2019-10-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Embecta Corp. (EMBC)2025-09-30$676.80M-7.9%
Tandem Diabetes Care Inc (TNDM)2025-12-31$546.01M+11.5%
Inspire Medical Systems, Inc. (INSP)2025-12-31$778.76M+14.6%
Haemonetics Corp (HAE)2026-03-28$787.59M+5.2%
Penumbra Inc (PEN)2025-12-31$942.44M+24.8%
Orthofix Medical Inc. (OFIX)2025-12-31$566.02M+3.7%
Merit Medical Systems Inc (MMSI)2025-12-31$738.27M+14.8%
Alphatec Holdings, Inc. (ATEC)2025-12-31$531.89M+25.4%
iRhythm Holdings, Inc. (IRTC)2025-12-31$527.25M+29.4%

Compare EMBC, TNDM, INSP, HAE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗